Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone continuation versus taper during tocilizumab maintenance in rheumatoid arthritis
2014-004673-16Phase 4Completed
- Sponsor
- Roche
- Start
- Jul 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tocilizumab and prednisone in rheumatoid arthritis (RA) (2 arms), sponsored by Roche. Started Jul 2015; status: completed.
02
Drugs
tocilizumabprednisone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2014-004673-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004673-16.